Rezolute (RZLT) Total Current Liabilities (2011 - 2026)
Rezolute (RZLT) reported Total Current Liabilities of $7.7 million for Q1 2026, down 26.67% on a YoY basis from $10.5 million in Q1 2025, and down 19.19% sequentially from $9.5 million in Q4 2025.
Rezolute (RZLT) Total Current Liabilities (2011 - 2026) Analysis & Trends
Rezolute (RZLT) has 16 years of Total Current Liabilities data on file, last reported at $7.7 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities fell 26.67% year-over-year to $7.7 million; the trailing twelve-month figure through Mar 2026 stood at $7.7 million (down 26.67% YoY), and the FY2025 full-year result was $11.9 million, up 24.01% from the prior year.
- Total Current Liabilities fell to $7.7 million in Q1 2026, from $9.5 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $11.9 million in Q2 2025 to a low of $2.4 million in Q3 2022.
- A 5-year average of $7.3 million and a median of $7.7 million in 2026 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities surged 200.0% in 2023 and decreased 26.67% in 2026, its largest moves.
- Tracing RZLT's Total Current Liabilities over 5 years: stood at $6.3 million in 2022, then increased by 27.11% to $8.0 million in 2023, then jumped by 32.37% to $10.6 million in 2024, then slipped by 10.1% to $9.5 million in 2025, then slipped by 19.19% to $7.7 million in 2026.
- Business Quant data shows RZLT's Total Current Liabilities at $7.7 million in Q1 2026, $9.5 million in Q4 2025, and $10.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Rezolute | 31,153.77 | 31,153.77 | - | 7.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.70 Mn |
| Dec 31, 2025 | 9.53 Mn |
| Sep 30, 2025 | 10.20 Mn |
| Jun 30, 2025 | 11.91 Mn |
| Mar 31, 2025 | 10.50 Mn |
| Dec 31, 2024 | 10.60 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | 9.61 Mn |
| Mar 31, 2024 | 6.96 Mn |
| Dec 31, 2023 | 8.01 Mn |
| Sep 30, 2023 | 7.20 Mn |
| Jun 30, 2023 | 5.20 Mn |
| Mar 31, 2023 | 4.39 Mn |
| Dec 31, 2022 | 6.30 Mn |
| Sep 30, 2022 | 2.40 Mn |
| Jun 30, 2022 | 2.46 Mn |
| Mar 31, 2022 | 2.90 Mn |
| Dec 31, 2021 | 6.40 Mn |
| Sep 30, 2021 | 2.60 Mn |
| Jun 30, 2021 | 1.97 Mn |